| イタリア | トルコ | オーストリア | |
| 低侵襲性脊椎固定術 | から $30,000 | から $5,400 | から $33,000 |
| 経皮的腰椎椎体間固定術 | から $20,500 | から $14,200 | - |
Bookimedは低侵襲性脊椎固定術価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで低侵襲性脊椎固定術代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。低侵襲性脊椎固定術で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。低侵襲性脊椎固定術の旅路でお一人になることはありません。
3,000件以上の脊椎手術を実施 – Lolli医師はマリア・チェチリア病院において脊椎変形に対する高度な治療を専門としています。
Minimally invasive fusion surgery in Italy achieves success rates between 88% and 95%. Leading centers like IRCCS Ospedale Galeazzi - Sant Ambrogio report a 91% success rate. These outcomes are supported by significant reductions in back pain and functional improvements measured by the Oswestry Disability Index.
Bookimed Expert Insight: While overall success is high, data shows IRCCS Ospedale Galeazzi - Sant Ambrogio handles 75% of Italy's revision surgeries. Choosing a high-volume center is vital because surgeons like Dr. Francesco Lolli at Maria Cecilia Hospital have performed over 3,000 procedures. This level of specialization often correlates with the lower 1–2% infection rates seen in Italian minimally invasive protocols.
Patient Consensus: Most patients report satisfaction with outcomes, but many emphasize the importance of smoking cessation to improve fusion odds. Others suggest aiming for significant functional improvement rather than expecting a total cure.
Minimally invasive spine fusion preserves muscles and soft tissues by using smaller incisions rather than detaching them from the bone. This modern approach significantly reduces blood loss, minimizes post-operative pain, and allows for shorter hospital stays and a faster return to daily activities.
Bookimed Expert Insight: While recovery is faster, patient data from Italy indicates that specialized centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio prioritize inpatient stays of up to 5 days. This ensuring-first-phase stability approach contrasts with outpatient trends elsewhere. Patients benefit from the clinic's high volume of 1,300+ spine surgeries annually, which correlates with better procedural safety.
Patient Consensus: Patients describe the transition as life-changing, often walking unaided on the first day. Many report returning to desk jobs within 2 weeks while utilizing significantly less pain medication than expected.
Leading surgeons for minimally invasive fusion surgery in Italy include Dr. Francesco Lolli at Maria Cecilia Hospital and Dr. Alessio Lovi at IRCCS Ospedale Galeazzi - Sant'Ambrogio. These specialists utilize advanced European-certified techniques, including unilateral biportal endoscopy and posterior lumbar fusion, within JCI-accredited research hospitals.
Bookimed Expert Insight: Milan has become a dominant hub because IRCCS Ospedale Galeazzi - Sant'Ambrogio performs 75% of all revision orthopedic surgeries in Italy. Patients seeking initial fusions should prioritize clinics with this high revision volume. This indicates superior management of complex cases and lower secondary complication rates.
Patient Consensus: Patients emphasize prioritizing endoscopic techniques over mini-open methods to reduce recovery from months to weeks. Many recommend private options in Milan to avoid long public health system wait times.
Minimally invasive fusion surgery in Italy typically requires 1 to 5 days of hospitalization. Most patients begin walking within 24 hours of the procedure. Desk work is often resumed within 2 to 4 weeks while full functional recovery usually occurs between 3 and 6 months.
Bookimed Expert Insight: Choosing centers in North-Western Italy often leads to shorter hospital stays. Facilities like IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan handle 5,000 operations annually. This high volume often results in more efficient 5-day protocols for complex posterior lumbar fusions.
Patient Consensus: Patients emphasize the importance of early movement and physical therapy for a faster recovery. Many report that minimally invasive techniques significantly reduced their need for long-term pain medication.